tiprankstipranks
Equillium: Ono to allow option to acquire rights to itolizumab to expire
PremiumThe FlyEquillium: Ono to allow option to acquire rights to itolizumab to expire
2M ago
Equillium temporarily pausing EQUATOR enrollment to review clinical options
Premium
The Fly
Equillium temporarily pausing EQUATOR enrollment to review clinical options
2M ago
Is EQ a Buy, Before Earnings?
Premium
Pre-Earnings
Is EQ a Buy, Before Earnings?
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Equillium announces data from EQ101 study
Premium
The Fly
Equillium announces data from EQ101 study
7M ago
Equillium: Interim enrollment achieved in Phase 3 EQUATOR study for aGVHD
Premium
The Fly
Equillium: Interim enrollment achieved in Phase 3 EQUATOR study for aGVHD
7M ago
EQ Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsEQ Upcoming Earnings Report: What to Expect?
9M ago
Equillium Inc Announces New Principal Accounting Officer and 2024 Inducement Plan
Premium
Company Announcements
Equillium Inc Announces New Principal Accounting Officer and 2024 Inducement Plan
9M ago
Equillium Inc Announces $21.95M Common Stock Offering
Premium
Company Announcements
Equillium Inc Announces $21.95M Common Stock Offering
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100